European Archives - Page 951 of 1369 - European Medical Journal

This site is intended for healthcare professionals

Continue
8 Mins
14 Nov 2019

Living with Alpha-1 Antitrypsin Deficiency: Empowering Patients and Healthcare Professionals

obstructive pulmonary disease is an umbrella term used to describe a number of progressive lung diseases, including emphysema and chronic bronchitis.
7 Mins
14 Nov 2019

Optimising Clinical Outcomes in Asthma and Chronic Obstructive Pulmonary Disease: Focus on Inhaler Satisfaction and Patient Adherence

The vast array of inhaler devices can be overwhelming for patients with chronic obstructive pulmonary disease (COPD) or asthma.
1 Mins
14 Nov 2019

What Do Patients Want in an Asthma App?

Asthma is estimated to affect 300 million people worldwide,1 and the literature advocates the beneficial effect of self-management programmes…
4 Mins
14 Nov 2019

Malignant Mesothelioma Presenting After Resolution of a Seemingly Benign Asbestos Related Pleural Effusion

This paper highlights the importance of ongoing follow-up in a patient with a label of benign asbestos-related pleural effusion.
3 Mins
14 Nov 2019

Unilateral Right Exophthalmia Revealing Systemic Sarcoidosis: A Case Report and a Review of the Literature
1 Mins
14 Nov 2019

Lung and Eye Pathology Develop Concurrently in a Neonatal Supplemental Oxygen Model

Bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) are two severe disorders that arise…
5 Mins
14 Nov 2019

A Case of Empyema and a Review of Practice in a District General Hospital

The Northumbria Healthcare NHS Foundation Trust serves just over half a million people across four different sites. There is a well-established…
1 Mins
14 Nov 2019

Obstructive Sleep Apnea and Objective Sleep Quality in Non-Dialysed Patients with Chronic Kidney Disease: An European Sleep Apnea Database (ESADA) Study

Short sleep duration and poor sleep quality have been reported in chronic kidney disease (CKD). Additionally, sleep disordered breathing (SDB)…
1 Mins
14 Nov 2019

Changes in Biomarkers in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib and Sildenafil

Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). Sildenafil is a phosphodiesterase-5…
2 Mins
14 Nov 2019

A Respiratory Review of Australian Men with Coal Mine Dust Lung Disease

In Queensland, Australia, coal mining is a large industry in terms of both employment and economy…
We’ve noticed you’re accessing
from North/South America.